Articles with public access mandates - Sami AlzareaLearn more
Not available anywhere: 1
Effects of α7 nicotinic acetylcholine receptor positive allosteric modulator on BDNF, NKCC1 and KCC2 expression in the hippocampus following lipopolysaccharide-induced …
M Abbas, S Alzarea, RL Papke, S Rahman
CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2021
Mandates: US National Institutes of Health
Available somewhere: 8
Nanoparticles in drug delivery: From history to therapeutic applications
O Afzal, ASA Altamimi, MS Nadeem, SI Alzarea, WH Almalki, A Tariq, ...
Nanomaterials 12 (24), 4494, 2022
Mandates: US National Institutes of Health
Sulfonamide-based 4-anilinoquinoline derivatives as novel dual Aurora kinase (AURKA/B) inhibitors: Synthesis, biological evaluation and in silico insights
MM Al-Sanea, A Elkamhawy, S Paik, K Lee, AM El Kerdawy, BSN Abbas, ...
Bioorganic & medicinal chemistry 28 (13), 115525, 2020
Mandates: US National Institutes of Health
The α7 nicotinic acetylcholine receptor positive allosteric modulator attenuates lipopolysaccharide-induced activation of hippocampal IκB and CD11b gene expression in mice
M Abbas, S Alzarea, RL Papke, S Rahman
Drug discoveries & therapeutics 11 (4), 206-211, 2017
Mandates: US National Institutes of Health
The α7 nicotinic acetylcholine receptor positive allosteric modulator prevents lipopolysaccharide-induced allodynia, hyperalgesia and TNF-α in the hippocampus in mice
M Abbas, S Alzarea, RL Papke, S Rahman
Pharmacological Reports 71 (6), 1168-1176, 2019
Mandates: US National Institutes of Health
The effect of an α-7 nicotinic allosteric modulator PNU120596 and NMDA receptor antagonist memantine on depressive-like behavior induced by LPS in mice: the involvement of …
S Alzarea, M Abbas, PJ Ronan, K Lutfy, S Rahman
Brain Sciences 12 (11), 1493, 2022
Mandates: US National Institutes of Health, US Department of Veterans Affairs
A kNGR peptide-tethered lipid–polymer hybrid nanocarrier-based synergistic approach for effective tumor therapy: development, characterization, ex-vivo, and in-vivo assessment
M Gupta, V Sharma, K Sharma, A Kumar, A Sharma, I Kazmi, ...
Pharmaceutics 14 (7), 1401, 2022
Mandates: National Health and Medical Research Council, Australia
The effect of an α-7 nicotinic allosteric modulator PNU120596 and NMDA receptor antagonist memantine on depressivelike behavior induced by LPS in mice: The involvement of brain …
S Alzarea, M Abbas, PJ Ronan, K Lutfy, S Rahman
s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2022
Mandates: US National Institutes of Health, US Department of Veterans Affairs
Anti-Hypertensive Activity of Some Selected Unani Formulations: An Evidence-Based Approach for Verification of Traditional Unani Claims Using LC-MS/MS for the Evaluation of …
MA Shaharyar, R Bhowmik, O Afzal, ASA Altamimi, SI Alzarea, ...
Journal of Clinical Medicine 11 (15), 4628, 2022
Mandates: Department of Science & Technology, India
Publication and funding information is determined automatically by a computer program